Psoriasis is characterized by multiple genetic variations. Some of these variations, such as the presence of HLA-Cw6 or TNFAIP3 single-nucleotide polymorphisms (SNPs), have been correlated to the response to biologic treatments.
Galluzzo, M., Boca, A.n., Botti, E., Potenza, C., Malara, G., Malagoli, P., et al. (2016). IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis. DERMATOLOGY, 232(2), 230-236 [10.1159/000441719].
IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis
Galluzzo M.;Botti E.;Chimenti S.;Talamonti M.;Costanzo A.
2016-01-01
Abstract
Psoriasis is characterized by multiple genetic variations. Some of these variations, such as the presence of HLA-Cw6 or TNFAIP3 single-nucleotide polymorphisms (SNPs), have been correlated to the response to biologic treatments.File in questo prodotto:
| File | Dimensione | Formato | |
|---|---|---|---|
|
Galluzzo - IL12B (p40) Gene Polymorphisms Contribute to Ustekinumab Response Prediction in Psoriasis.pdf
solo utenti autorizzati
Tipologia:
Versione Editoriale (PDF)
Licenza:
Copyright dell'editore
Dimensione
186.52 kB
Formato
Adobe PDF
|
186.52 kB | Adobe PDF | Visualizza/Apri Richiedi una copia |
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
